Top

Cancer Causes & Control

Published in:

01-11-2012 | Original paper

Regular dental visits are associated with earlier stage at diagnosis for oral and pharyngeal cancer

Authors: Scott M. Langevin, Dominique S. Michaud, Melissa Eliot, Edward S. Peters, Michael D. McClean, Karl T. Kelsey

Published in: Cancer Causes & Control | Issue 11/2012

Abstract

Purpose

Oral and pharyngeal cancer patients diagnosed at an advanced stage experience increased morbidity and mortality relative to those with localized disease. The aim of this study was to assess the impact of dental insurance status and regularity of dental visits on early detection of oral and pharyngeal cancer.

Methods

We examined the relationship of dental insurance and frequency of dental visits with stage at diagnosis among 441 oral and pharyngeal cancer cases from a population-based study of head and neck cancer. Ordinal logistic regression models were used to assess the association with stage, and tumor (T) and nodal (N) classification.

Results

Never or rarely going to the dentist was associated with being diagnosed at higher stage for oral and pharyngeal cancer (cumulative OR = 2.28, 95 % CI: 1.02–5.10) and oral cancer (cumulative OR = 9.17, 95 % CI: 2.70–31.15) compared to those going to the dentist at least annually. Oral and pharyngeal cancer patients who went to the dentist infrequently (cumulative OR = 1.82, 95 % CI: 1.09–3.05) or rarely/never (cumulative OR = 3.24, 95 % CI: 1.59–6.57) were diagnosed with a higher T classification compared with those who went at least annually.

Conclusions

Receipt of regular dental examinations at least annually may reduce the public health burden of oral and pharyngeal cancer by facilitating earlier detection of the disease.

Siegel R, Ward E, Brawley O, Jemal A (2011) Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61(4):212–236. doi:10.3322/caac.20121 PubMedCrossRef

Carvalho AL, Nishimoto IN, Califano JA, Kowalski LP (2005) Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer 114(5):806–816. doi:10.1002/ijc.20740 PubMedCrossRef

Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA, Edwards DK (2011) SEER cancer statistics, review, 1975–2008. National Cancer Institute, Bethesda, MD

Healthy People 2010: Oral Health (2000) U.S. Department of Health and Human Services, Washington, DC

Argiris A, Karamouzis MV, Raben D, Ferris RL (2008) Head and neck cancer. Lancet 371(9625):1695–1709. doi:10.1016/S0140-6736(08)60728-X PubMedCrossRef

Wineland AM, Stack BC Jr (2008) Modern methods to predict costs for the treatment and management of head and neck cancer patients: examples of methods used in the current literature. Curr Opin Otolaryngol Head Neck Surg 16(2):113–116PubMedCrossRef

Warnakulasuriya KA, Johnson NW (1996) Strengths and weaknesses of screening programmes for oral malignancies and potentially malignant lesions. Eur J Cancer Prev 5(2):93–98PubMedCrossRef

Lim K, Moles DR, Downer MC, Speight PM (2003) Opportunistic screening for oral cancer and precancer in general dental practice: results of a demonstration study. Br Dent J 194(9):497–502; discussion 493. doi:10.1038/sj.bdj.4810069

Speight PM, Palmer S, Moles DR, Downer MC, Smith DH, Henriksson M, Augustovski F (2006) The cost-effectiveness of screening for oral cancer in primary care. Health Technol Assess 10(14):1–144, iii–iv

10.

Netuveli G, Sheiham A, Watt RG (2006) Does the ‘inverse screening law’ apply to oral cancer screening and regular dental check-ups? J Med Screen 13(1):47–50. doi:10.1258/096914106776179836 PubMedCrossRef

11.

Yusof ZY, Netuveli G, Ramli AS, Sheiham A (2006) Is opportunistic oral cancer screening by dentists feasible? An analysis of the patterns of dental attendance of a nationally representative sample over 10 years. Oral Health Prev Dent 4(3):165–171PubMed

12.

Kujan O, Glenny AM, Oliver RJ, Thakker N, Sloan P (2006) Screening programmes for the early detection and prevention of oral cancer. Cochrane Database Syst Rev 3:CD004150. doi:10.1002/14651858.CD004150.pub2

13.

Mashberg A (2000) Diagnosis of early oral and oropharyngeal squamous carcinoma: obstacles and their amelioration. Oral Oncol 36(3):253–255PubMedCrossRef

14.

LeHew CW, Epstein JB, Kaste LM, Choi YK (2010) Assessing oral cancer early detection: clarifying dentists’ practices. J Public Health Dent 70(2):93–100. doi:10.1111/j.1752-7325.2009.00148.x PubMed

15.

MacCarthy D, Flint SR, Healy C, Stassen LF (2011) Oral and neck examination for early detection of oral cancer—a practical guide. J Ir Dent Assoc 57(4):195–199PubMed

16.

Oral Health U.S., 2002 (2002) National Institute of Dental and Craniofacial Research of the National Institutes of Health, Rockville, MD

17.

Oral Health, U.S. 2002 Annual Report (2002) National Institute of Dental and Craniofacial Research Bethesda, MD

18.

Manski RJ, Moeller J, Chen H, St Clair PA, Schimmel J, Magder L, Pepper JV (2010) Dental care expenditures and retirement. J Public Health Dent 70(2):148–155. doi:10.1111/j.1752-7325.2009.00156.x PubMed

19.

Kwok J, Langevin SM, Argiris A, Grandis JR, Gooding WE, Taioli E (2010) The impact of health insurance status on the survival of patients with head and neck cancer. Cancer 116(2):476–485. doi:10.1002/cncr.24774 PubMedCrossRef

20.

Chen AY, Schrag NM, Halpern MT, Ward EM (2007) The impact of health insurance status on stage at diagnosis of oropharyngeal cancer. Cancer 110(2):395–402. doi:10.1002/cncr.22788 PubMedCrossRef

21.

Chen AY, Schrag NM, Halpern M, Stewart A, Ward EM (2007) Health insurance and stage at diagnosis of laryngeal cancer: does insurance type predict stage at diagnosis? Arch Otolaryngol Head Neck Surg 133(8):784–790. doi:10.1001/archotol.133.8.784 PubMedCrossRef

22.

Applebaum KM, McClean MD, Nelson HH, Marsit CJ, Christensen BC, Kelsey KT (2009) Smoking modifies the relationship between XRCC1 haplotypes and HPV16-negative head and neck squamous cell carcinoma. Int J Cancer 124(11):2690–2696. doi:10.1002/ijc.24256 PubMedCrossRef

23.

Liang C, McClean MD, Marsit C, Christensen B, Peters E, Nelson HH, Kelsey KT (2009) A population-based case–control study of marijuana use and head and neck squamous cell carcinoma. Cancer Prev Res (Phila) 2(8):759–768. doi:10.1158/1940-6207.CAPR-09-0048 CrossRef

24.

D’Agostino RB, Belanger A, D’Agostino RBJ (1990) A suggestion for using powerful and informative tests of normality. Am Stat 44(4):316–321

25.

Mccullagh P (1980) Regression-models for ordinal data. J R Stat Soc B Met 42(2):109–142

26.

Edge S, Byrd D, Compton C, Fritz A, Greene F, Trotti A (eds) (2009) American joint committee on cancer staging manual, 7th edn. Springer, New York

27.

Greenland S, Finkle WD (1995) A critical look at methods for handling missing covariates in epidemiologic regression analyses. Am J Epidemiol 142(12):1255–1264PubMed

28.

Brant R (1990) Assessing proportionality in the proportional odds model for ordinal logistic-regression. Biometrics 46(4):1171–1178PubMedCrossRef

29.

Elwood JM, Gallagher RP (1985) Factors influencing early diagnosis of cancer of the oral cavity. CMAJ 133(7):651–656PubMed

30.

Watson JM, Logan HL, Tomar SL, Sandow P (2009) Factors associated with early-stage diagnosis of oral and pharyngeal cancer. Commun Dent Oral Epidemiol 37(4):333–341. doi:10.1111/j.1600-0528.2009.00470.x CrossRef

31.

Groome PA, Rohland SL, Hall SF, Irish J, Mackillop WJ, O’Sullivan B (2011) A population-based study of factors associated with early versus late stage oral cavity cancer diagnoses. Oral Oncol 47(7):642–647. doi:10.1016/j.oraloncology.2011.04.018 PubMedCrossRef

32.

Holmes JD, Dierks EJ, Homer LD, Potter BE (2003) Is detection of oral and oropharyngeal squamous cancer by a dental health care provider associated with a lower stage at diagnosis? J Oral Maxillofac Surg 61(3):285–291. doi:10.1053/joms.2003.50056 PubMedCrossRef

33.

National Health Expenditure Projections 2010–2020 (2011) Centers for medicare and medicaid services. Office of the Actuary, Baltimore, MD

34.

Applebaum E, Ruhlen TN, Kronenberg FR, Hayes C, Peters ES (2009) Oral cancer knowledge, attitudes and practices: a survey of dentists and primary care physicians in Massachusetts. J Am Dent Assoc 140(4):461–467PubMed

35.

Gajendra S, Cruz GD, Kumar JV (2006) Oral cancer prevention and early detection: knowledge, practices, and opinions of oral health care providers in New York State. J Cancer Educ 21(3):157–162. doi:10.1207/s15430154jce2103_14 PubMedCrossRef

36.

Lehew CW, Kaste LM (2007) Oral cancer prevention and early detection knowledge and practices of Illinois dentists—a brief communication. J Public Health Dent 67(2):89–93PubMedCrossRef

37.

Silverman S Jr, Kerr AR, Epstein JB (2010) Oral and pharyngeal cancer control and early detection. J Cancer Educ 25(3):279–281. doi:10.1007/s13187-010-0045-6 PubMedCrossRef

38.

Horowitz AM, Drury TF, Canto MT (2000) Practices of Maryland dentists: oral cancer prevention and early detection—baseline data from 1995. Oral Dis 6(5):282–288PubMedCrossRef

39.

Yellowitz JA, Horowitz AM, Drury TF, Goodman HS (2000) Survey of U.S. dentists’ knowledge and opinions about oral pharyngeal cancer. J Am Dent Assoc 131(5):653–661PubMed

40.

Patton LL, Ashe TE, Elter JR, Southerland JH, Strauss RP (2006) Adequacy of training in oral cancer prevention and screening as self-assessed by physicians, nurse practitioners, and dental health professionals. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102(6):758–764. doi:10.1016/j.tripleo.2005.10.072 PubMedCrossRef

41.

van der Waal I, de Bree R, Brakenhoff R, Coebergh JW (2011) Early diagnosis in primary oral cancer: is it possible? Med Oral Patol Oral Cir Bucal 16(3):e300–e305PubMedCrossRef

42.

Sturgis EM, Cinciripini PM (2007) Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer 110(7):1429–1435PubMedCrossRef

43.

Shiboski CH, Schmidt BL, Jordan RC (2005) Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20–44 years. Cancer 103(9):1843–1849. doi:10.1002/cncr.20998 PubMedCrossRef

Title: Regular dental visits are associated with earlier stage at diagnosis for oral and pharyngeal cancer
Authors: Scott M. Langevin
Dominique S. Michaud
Melissa Eliot
Edward S. Peters
Michael D. McClean
Karl T. Kelsey
Publication date: 01-11-2012
Publisher: Springer Netherlands
Published in: Cancer Causes & Control / Issue 11/2012
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI: https://doi.org/10.1007/s10552-012-0061-4

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 11/2012

Associations of type 2 diabetes and diabetes treatment with breast cancer risk and mortality: a population-based cohort study among British women

NQO1 rs1800566 (C609T), PON1 rs662 (Q192R), and PON1 rs854560 (L55M) polymorphisms segregate the risk of childhood acute leukemias according to age range distribution

A case-parent triad assessment of folate metabolic genes and the risk of childhood acute lymphoblastic leukemia

Non-steroidal anti-inflammatory drug use and ovarian cancer risk: findings from the NIH-AARP Diet and Health Study and systematic review

Critical review and synthesis of the epidemiologic evidence on formaldehyde exposure and risk of leukemia and other lymphohematopoietic malignancies

Intake of omega-3 and omega-6 fatty acids and risk of ovarian cancer

Keynote webinar | Spotlight on antibody–drug conjugates in cancer